Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning
1 other identifier
interventional
16
1 country
1
Brief Summary
The investigators aimed to assess the ability of a modified version of Behavioral Activation for occupational and social improvement to produce change in: 1. social adjustment, 2. work functioning, 3. avoidance behavior and 4. behavioral activation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 25, 2013
CompletedFirst Posted
Study publicly available on registry
February 4, 2013
CompletedResults Posted
Study results publicly available
June 19, 2017
CompletedJune 19, 2017
April 1, 2017
2.5 years
January 25, 2013
January 5, 2017
April 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Paid Work Hours at Week 12
Subject-reported paid work hours per week at week 12
Week 12
Paid Work Hours at Week Baseline
Subject-reported paid work hours per week at week baseline
Baseline
Secondary Outcomes (2)
Social Functioning at Week Baseline on the Social Adjustment Scale
baseline
Social Functioning at Week 12 on the Social Adjustment Scale
Week 12
Study Arms (1)
Behavioral Activation for Return to Work
EXPERIMENTALBA is a manualized psychotherapy with comparable efficacy to cognitive behavioral treatment and antidepressant medication for acute treatment of depression. In this study, BA's focus was shifted to target work dysfunction by activating the patient into employment-related goals. BA-W consisted of 12 50-minute weekly sessions. Conceptualizing work dysfunction as a product of avoidance patterns and low levels of positive reinforcement, the treatment addressed maladaptive coping strategies such as avoidance as maintaining work dysfunction beyond remission of symptoms. Rather than broadly activating patients, activity scheduling focused on tasks such as sending out resumes, calling for job interviews, and networking to meet potential employers.
Interventions
See Arm Description
Eligibility Criteria
You may qualify if:
- adults aged 20-75 years
- a primary diagnosis of Dysthymic Disorder, Chronic major depressive disorder or double depression
- a \>50% decrease in 17 item Hamilton Rating Scale for Depression (HRSD-17) score and a final HRSD-17 score ≤ 10 with an adequate antidepressant medication (ADM) trial (\> 4 weeks on at least 50% Physician's Desk Reference maximum ADM dose)
- a rating of 1 ("very much improved") or 2 ("much improved") on the Clinical Global Impressions-Improvement scale (CGI-I)
- continued functional impairment, defined by scores \>1.9 on the Social Adjustment Scale (SAS)
- unemployment (jobless, looking for work) according to the Bureau of Labor Statistics: jobless and looking and available for work, or underemployed.
You may not qualify if:
- Structured Clinical Interview for Diagnostic and Statistical Manual, fourth edition (DSM-IV) Axis I disorders-diagnosed cognitive or psychotic disorders
- bipolar disorder
- active eating disorders
- severe borderline personality disorder
- alcohol or drug dependence (except nicotine) in the last 6 months
- current suicide risk
- unstable medical conditions
- use of psychotropic medications other than antidepressants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York State Psychiatric Institute
New York, New York, 10032, United States
Related Publications (2)
Erickson G, Hellerstein DJ. Behavioral activation therapy for remediating persistent social deficits in medication-responsive chronic depression. J Psychiatr Pract. 2011 May;17(3):161-9. doi: 10.1097/01.pra.0000398409.21374.ab.
PMID: 21586994BACKGROUNDHellerstein DJ, Erickson G, Stewart JW, McGrath PJ, Hunnicutt-Ferguson K, Reynolds SK, O'Shea D, Chen Y, Withers A, Wang Y. Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction. Compr Psychiatry. 2015 Feb;57:140-7. doi: 10.1016/j.comppsych.2014.10.015. Epub 2014 Nov 7.
PMID: 25464836RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This was a small open treatment study, without a comparator group and with limited followup. Findings of this pilot study should be replicated in a larger prospective trial with a randomized design, and with longer followup.
Results Point of Contact
- Title
- David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia
- Organization
- NY State Psychiatric Institute
Study Officials
- PRINCIPAL INVESTIGATOR
David J Hellerstein, MD
New York State Psychiatric Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2013
First Posted
February 4, 2013
Study Start
June 1, 2010
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
June 19, 2017
Results First Posted
June 19, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share